About
Contact & Profiles
A5093561932
Research Areas
- HIV Research and Treatment
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
University of the Witwatersrand
2023
Background: Protease inhibitors (PIs) have been recommended as World Health Organization second-line antiretroviral therapy (ART) for low- to middle-income countries two decades. As dolutegravir-based regimens become widely available, the future role of PIs is uncertain.Objectives: To describe characteristics patients on PI-based ART (in first-line and regimens), double-boosted protease (DBPI) who received recycled nucleoside reverse transcriptase (NRTI) in at a tertiary level clinic.Method:...
10.4102/sajhivmed.v24i1.1536
article
EN
cc-by
Southern African Journal of HIV Medicine
2023-12-21
Coming Soon ...